Skip to main content
. 2018 Nov 20;38:89–99. doi: 10.1016/j.ebiom.2018.11.012

Fig. 6.

Fig. 6

ADAM10 and APP co-expression associated with poor outcome in non-luminal breast cancers. Disease free survival and breast cancer specific survival of non-luminal breast cancer according to combined analysis of ADAM10 and APP expression by IHC using Kaplan-meier analysis. ADAM10hiAPPhi cases (purple line) showed the worst DFS and BCSS compared to ADAM10loAPPlo cases (blue line), ADAM10loAPPhi cases (green line) and ADAM10hiAPPlo cases (beige line).